NEW YORK (GenomeWeb News) - Thermo Fisher Scientific said today that it has acquired Open Biosystems, a privately held provider of RNAi research products, for an undisclosed sum.
Thermo Fisher said in a statement that the acquisition "significantly expands" its presence in the RNAi field because Open Biosystems' specialty, short-hairpin RNA, complements the small-interfering RNA technology it already sells through its Thermo Scientific Dharmacon product line.
...and receive Daily News bulletins.
Already have an account?Login Now.
US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.
Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.
In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.
In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.